Fig. 1 · Structure
Documents & Downloads
Orbofiban
platelet GPIIb/IIIa antagonist
Orbofiban is an orally active antagonist of the platelet glycoprotein IIb/IIIa receptor, which plays a critical role in platelet aggregation and thrombus formation. By inhibiting this receptor, Orbofiban effectively reduces platelet aggregation, making it a valuable tool for research into thrombosis and cardiovascular diseases. Its application extends to studies focused on the mechanisms of platelet function and the development of antiplatelet therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 163250-90-6 |
| Applications | platelet GPIIb/IIIa antagonist |
| Formula | C17H23N5O4 |
| Molecular Weight | 361.40 |
| SMILES | O=C1N(C(C=C2)=CC=C2C(N)=N)CC[C@@H]1NC(NCCC(OCC)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.